RICHMOND - Patients with opioid use disorder (OUD) who maintain high adherence to SUBLOCADE, a monthly injectable buprenorphine treatment, experienced significantly lower relapse rates and reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback